| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 740.5K | $19.74M | - | |
| Other | 150.2K | $4.00M | - | |
| Other | 127.6K | $3.40M | - | |
| Other | 120.2K | $3.21M | - | |
| CFO | 86.0K | $2.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2022 | Watanabe Todd Franklin65 | President And CEO | Sale+OE | 1,000 | $17.00 | $17,000.00 | -0.2% | +11.8% | -2.2% | |
| Jan 5, 2022 | Watanabe Todd Franklin65 | President And CEO | Sale+OE | 1,000 | $21.59 | $21,592.00 | - | +3.2% | -25.6% | |
| Jan 3, 2022 | Welgus Howard G.61 | Director | Sale+OE | 2,500 | $21.21 | $53,029.50 | -1.4% | -6.3% | -35.2% | |
| Dec 27, 2021 | Burrows Scott L74 | Chief Financial Officer | Sell | 12,560 | $20.07 | $252,139.49 | -35.6% | -13.7% | -30.5% | |
| Dec 23, 2021 | Welgus Howard G.61 | Director | Sale+OE | 2,500 | $20.16 | $50,395.50 | -1.4% | -12.5% | -28.9% | |
| Dec 8, 2021 | Watanabe Todd Franklin65 | President And CEO | Sale+OE | 1,000 | $17.00 | $17,000.00 | -0.2% | -3.9% | +4.0% | |
| Nov 5, 2021 | Watanabe Todd Franklin65 | President And CEO | Sale+OE | 1,000 | $21.50 | $21,501.60 | -0.2% | -33.4% | -18.5% | |
| Nov 1, 2021 | Welgus Howard G.61 | Director | Sale+OE | 2,500 | $21.81 | $54,524.00 | -1.4% | -33.9% | -20.3% | |
| Oct 5, 2021 | Watanabe Todd Franklin65 | President And CEO | Sale+OE | 2,500 | $24.92 | $62,293.50 | -0.4% | -10.6% | -21.8% | |
| Oct 1, 2021 | Welgus Howard G.61 | Director | Sale+OE | 2,500 | $23.87 | $59,679.75 | -1.4% | -18.8% | -24.2% |